Skip to content

Prostate cancer: ‘Most common organ cancer affecting men’ – experts share early detection and treatment | health news


Prostate cancer, a widespread menace affecting men worldwide, often operates in stealth mode in its early stages. Unbeknownst to individuals, the disease can progress silently within the confines of the prostate organ. This emphasizes the critical need for heightened awareness and proactive action, particularly in early detection.

Dr. Ajay S. According to Shetty, Lead Consultant – Urology Renal Transplantation and Robotics Surgeon, Manipal Hospital Jaswantpur and Hebbal, “Prostate cancer is the most common solid organ cancer affecting men worldwide. Most prostate cancers grow slowly and cause no symptoms. Early Stages when the disease is confined to the prostate. More advanced prostate cancer can cause symptoms such as difficulty urinating, slow flow, blood in the urine, bone pain or weight loss. So it is important that patients do not wait for symptoms. And if you have a positive family history If they have a history, get themselves screened and evaluated for prostatic conditions when they are 50 years of age or before they reach 45 years of age.”

Prostate cancer: Asymptomatic early stages

In its early stages, prostate cancer remains largely asymptomatic, making it essential for men age 50 and older to receive regular screening. However, those with a positive family history should take an active stance before the age of 45.

Prostate Cancer: The Importance of Physical Examination

When starting the screening process, a thorough physical examination is helpful in clearly identifying irregularities or abnormalities. This hands-on approach lays the foundation for subsequent diagnostic steps.

The journey to prostate cancer detection deepens with the help of ultrasound examination. This diagnostic tool provides detailed visuals of the prostate, providing valuable insight into potential concerns that may escape surface-level assessment.

Central to early diagnosis lies the prostate-specific antigen (PSA) blood test. This test serves as a linchpin in detecting subtle PSA level changes, serving as an early warning system for potential prostate abnormalities. Regular monitoring forms the basis of effective management.

Abnormal results from a physical exam, ultrasound, or PSA test warrant a closer look. Magnetic resonance imaging (MRI) moves into the diagnostic phase, providing detailed images to pinpoint potential cancerous growths with precision.

Demanding paradigmatic confirmation, a biopsy of the prostate becomes the final diagnostic arbiter. While invasive, this procedure provides a definitive diagnosis of prostate cancer by removing tissue samples for in-depth examination.

Understanding the paramount importance of early detection uncovers a shield against the hidden menace of prostate cancer. Regular screenings, including physical exams, ultrasounds and PSA tests, empower individuals to take charge of their health. This proactive stance ensures timely intervention, significantly increasing the likelihood of successful management and improved outcomes in prostate cancer.

The prostate cancer detection journey unfolds through strategic subheadings, guiding individuals toward informed decisions and proactive health management.